Related by context. All words. (Click for frequent words.) 68 salmeterol fluticasone 68 MAGE A3 ASCI 66 subcutaneously administered 66 relapsed MM 65 somatostatin analog 65 tizanidine hydrochloride short 65 Tarceva TM 65 maximally tolerated dose 65 beta 1a 65 ZOLINZA 65 CIMZIA ™ 64 Pegloticase 64 CANCIDAS 64 forodesine 64 NPH insulin 64 orally administered inhibitor 64 uric acid lowering 64 herpetic keratitis 64 clonidine hydrochloride 64 midstage clinical 64 RAPTIVA 64 analgesic efficacy 63 Anidulafungin 63 ACTEMRA TM 63 metformin sulfonylurea 63 xanthine oxidase inhibitor 63 pharmacodynamics PD 63 APTIVUS r 63 tolerability profiles 63 Zemplar Capsules 63 divalproex sodium 63 aplindore 63 R Saizen R 63 TELINTRA 63 INVEGA ® 63 RhuDex ® 63 MKC# MT 63 pharmacologically active isomer 63 idraparinux 63 latrepirdine 63 ARCALYST ® 63 LATUDA 63 pharmacodynamic properties 62 tolterodine 62 peripherally acting 62 leukotriene receptor antagonists 62 Panzem R 62 Factor VIIa 62 ritonavir boosted 62 fluticasone furoate 62 Frova ® 62 LEVAQUIN ® 62 subcutaneous SC 62 R# #mg BID 62 #mg doses [002] 62 acetonide FA 62 paroxetine sertraline 62 oral talactoferrin 62 trospium chloride 62 interferon alfa 2b 62 desvenlafaxine succinate 62 H2RAs 62 R brand eszopiclone 62 oral picoplatin 62 Zenvia ™ 62 CYT# QbG# 62 subcutaneous insulin 62 SinuNase ™ 62 sulindac 62 oxymorphone ER 62 AAG geldanamycin analog 62 azilsartan medoxomil 62 RLAI 62 ALN HPN 62 pegylated interferons 62 visilizumab 62 CYT# potent vascular disrupting 62 alfuzosin 61 chlorambucil 61 ALGRX 61 H2 antagonists 61 orally inhaled 61 hoFH 61 hypoxia activated prodrug 61 PEGINTRON TM 61 Prilosec omeprazole 61 IV Busulfex 61 FUSILEV enhances 61 PGL# 61 anticholinergic agents 61 coadministration 61 Bicalutamide 61 FOSRENOL ® 61 PSMA ADC 61 ritonavir boosted atazanavir 61 corticosteroid dose 61 azelastine 61 EMBEDA ™ 61 guanfacine 61 Glimepiride 61 Romidepsin 61 betamethasone dipropionate 61 Cariprazine 61 thetreatment 61 albiglutide 61 RSD# oral 61 ULTRAM ER 61 oral prednisolone 61 oral antidiabetic 61 adenosine injection 61 plus prednisone prednisolone 61 rufinamide 61 CIMZIA TM 61 EXPAREL TM 61 Engerix B 61 insulin lispro 61 alfa 2a 61 Daclizumab 61 insulin detemir 61 abacavir lamivudine 61 mometasone 61 3mg/kg 61 norepinephrine reuptake inhibitor 61 Pegasys peginterferon alfa 2a 61 Fluticasone 61 PRT# 61 NMDA antagonist 61 pharmacokinetic equivalence 61 Octreotide 60 IOP lowering 60 markets HP Acthar 60 q8h 60 superficial bladder cancer 60 active comparator 60 Perforomist ™ Inhalation Solution 60 nadolol 60 beclomethasone dipropionate 60 Initiates Enrollment 60 non splenectomized 60 rosuvastatin Crestor 60 prokinetic agent 60 cannabinor 60 CONCERTA 60 fosbretabulin 60 Certolizumab 60 lipid lowering agents 60 NATRECOR R 60 saline placebo 60 Aloxi injection 60 SUSTENNA TM 60 risperidone Risperdal 60 pharmacodynamic parameters 60 CIMZIA R 60 thrombin inhibiting aptamer 60 IL# PE#QQR 60 zolmitriptan 60 Alkeran 60 metformin sulfonylureas 60 RISPERDAL ® 60 EndoTAG TM -1 60 venlafaxine ER 60 PDE4 inhibitor 60 DexaSite 60 PegIFN RBV 60 recurrent genital herpes 60 Fibrillex TM 60 tapentadol ER 60 short acting bronchodilator 60 oral transmucosal 60 tapentadol IR 60 acitretin 60 Adenoscan R 60 pharmacokinetic characteristics 60 SILENOR 60 class mGluR5 inhibitor 60 SAR# [002] 60 CorVue ™ 60 inhaled formulation 60 OvaRex R 60 ADAGEN 60 Budesonide foam crofelemer 60 tacrolimus ointment 60 hour bronchodilation 60 FOLFOX regimen 60 #:# randomization 59 Initiates Clinical Trial 59 opioid induced bowel dysfunction 59 Insulin PH# 59 novel emulsion formulation 59 sitaxsentan 59 certolizumab 59 venlafaxine XR 59 Initiates Clinical 59 5-FU/LV 59 Omacetaxine mepesuccinate 59 Begins Dosing 59 beclomethasone 59 Sudhir Agrawal D.Phil 59 immunomodulatory therapy 59 Known hypersensitivity 59 ARB telmisartan 59 sapropterin dihydrochloride 59 SomatoKine R 59 Vildagliptin 59 prednisone prednisolone plus 59 gemifloxacin 59 nilotinib Tasigna ® 59 IIIa inhibitor 59 antimuscarinic agent 59 Saizen R 59 nicardipine 59 antiretroviral naive 59 mg TID 59 Gabapentin GR 59 acarbose 59 ARIKACE ™ 59 urinary N telopeptide 59 levocetirizine 59 Somatuline R Depot 59 ß blockers 59 postsurgical pain 59 TMC# r 59 Focalin XR 59 EMBEDA TM 59 ropinirole Requip 59 alefacept 59 oxycodone IR 59 preclinical pharmacokinetic 59 XOPENEX Inhalation Solution 59 pharmacokinetic parameters 59 2A receptor agonist 59 alicaforsen enema 59 inhaled budesonide 59 #mg dose [001] 59 omeprazole Prilosec 59 Starlix 59 plus dexamethasone 59 fluvastatin 59 oxypurinol 59 Effexor venlafaxine 59 evaluating picoplatin 59 LUNESTA ® 59 PegIntron 59 Metoprolol 59 Keppra XR 59 antiarrhythmic drug 59 targeted radiotherapeutic 59 efficacy tolerability 59 STELARA ® 59 DIFICID ™ 59 CORDAPTIVE 59 pyrexia mucositis sepsis febrile 59 #.#mg/dL 59 febuxostat 59 aspirin clopidogrel 59 FASLODEX 59 urate lowering 59 atorvastatin #mg 59 statin simvastatin 59 tenofovir emtricitabine 59 proprietary intravenous formulation 59 #mg dose [003] 59 benign prostatic hypertrophy BPH 59 pegylated interferon alpha 59 telaprevir dosing 59 glatiramer acetate 59 randomized multicenter Phase III 59 8mg/kg 58 low dose cytarabine 58 oral diclofenac 58 oral methylnaltrexone 58 terfenadine 58 inhaled iloprost 58 Oxcarbazepine 58 pharmacokinetics PK 58 dosage regimens 58 OADs 58 DepoDur TM 58 INVEGA R 58 TOVIAZ 58 ALN PCS 58 Oracea TM 58 CYCLOSET 58 5 HT2C receptor 58 Insulin detemir 58 Dextofisopam 58 pegylated liposomal doxorubicin 58 sitagliptin Januvia 58 Tasimelteon 58 lispro 58 ACEIs 58 KAPIDEX 58 mometasone furoate 58 factor TNF 58 risedronate sodium tablets 58 Iloperidone 58 topiramate Topamax 58 recurrent glioblastoma multiforme 58 myopathy rhabdomyolysis 58 ROZEREM TM 58 prokinetic 58 inhaled anticholinergics 58 IMiDs R 58 antidepressants SSRIs 58 rimonabant #mg 58 erythropoietic 58 weekly subcutaneous injections 58 fluoxetine paroxetine 58 fluticasone salmeterol 58 IAP inhibitor 58 ACOMPLIA R 58 Edarbi 58 IGF 1R inhibitor 58 diarrhea predominant irritable 58 Liprotamase 58 topical antifungal 58 #mg/day [002] 58 administered subcutaneously 58 Fibrin Pad 58 bezafibrate 58 Evoltra ® 58 nebulized formoterol fumarate 58 CD# CEA 58 budesonide pMDI 58 protease inhibitor PI 58 zafirlukast 58 adjunctive placebo 58 glargine 58 sulfonylurea metformin 58 Oxypurinol 58 AGILECT R 58 intravenous dosing 58 Xcytrin R 58 TRISENOX ® 58 PHX# 58 tiagabine 58 investigational atypical antipsychotic 58 rFSH 58 levalbuterol 58 antiarrhythmic 58 Perforomist Inhalation Solution 58 H2 receptor antagonists 58 QVAR ® 58 GLP1 agonist 58 exocrine pancreatic insufficiency 58 incyclinide 58 Ambrisentan 58 unresectable HCC 58 severe gastroparesis 58 #mg q8h 58 mg/m2 cohort 58 Pharmacokinetic parameters 58 STRIDE PD 58 levetiracetam 58 MNTX 58 deferoxamine 58 nasal formulation 58 balsalazide 58 Catapres 58 thiazolidinedione TZD 58 reactogenicity 58 antiviral efficacy 58 inhaled corticosteroid ICS 58 Eloxatin R 58 constipation OIC 58 factor Xa inhibitor 58 tricyclic 58 pioglitazone HCl 58 CEQ# 58 norethindrone acetate 58 ATL/TV# 58 adriamycin 58 Lipitor #mg 58 headache nasopharyngitis 58 Known generically 57 peak plasma concentrations 57 insulin sensitizing 57 reversing heparin 57 moderate renal impairment 57 5 Fluorouracil 57 parecoxib 57 CNS depressant 57 R adefovir dipivoxil 57 coronary stent merged 57 Phase #b/#a clinical 57 Tasigna prolongs 57 Zoraxel TM 57 topical calcineurin inhibitors 57 triphendiol 57 mTOR inhibition 57 PEGylated interferon 57 lucinactant 57 Taxotere chemotherapy 57 tipranavir r 57 Soliris eculizumab 57 Personalized Immunotherapy 57 bronchodilation 57 NATRECOR ® 57 moderate hepatic impairment 57 inhaled glucocorticoids 57 oral ribavirin 57 pegylated IFN 57 systemic immunosuppressive drugs 57 rizatriptan 57 P#X# antagonist 57 QVAR R 57 formoterol fumarate 57 humanised monoclonal antibody 57 pegylated interferon alfa 2b 57 acute gout flares 57 efalizumab 57 noscapine 57 dose escalation phase 57 MGd 57 GVAX ® 57 Guanilib 57 MAXY G# 57 intradermal injections 57 dose proportional pharmacokinetics 57 Restanza TM 57 titrated glipizide 57 Major Depressive Disorder MDD 57 Mesafem 57 maximally tolerated 57 immunomodulator 57 lumiracoxib 57 estrogen receptor antagonist 57 pooled comparator 57 pharmacokinetic profiles 57 Febrile neutropenia 57 USL# 57 rFIXFc 57 isoproterenol 57 Viprinex TM 57 Lopressor 57 ACV1 57 CCR9 antagonist 57 schizophrenia CIAS 57 bupropion SR 57 pathophysiological effects 57 ARIMIDEX 57 Kyowa Kirin 57 FOLOTYN ® 57 antiinflammatory 57 ancrod 57 thienopyridines 57 Shigamabs ® 57 Immunotherapeutic 57 ICS LABA combination 57 benazepril 57 mg subcutaneous 57 anticholinergic 57 Perforomist TM Inhalation Solution 57 balsalazide tablet 57 lacosamide 57 fusion enhancers 57 dacarbazine 57 Symadex 57 Bystolic nebivolol 57 clinically meaningful reductions 57 Inhaled nitric oxide 57 cholestyramine 57 4mg/kg 57 maximally tolerated lipid lowering 57 HDL Selective Delipidation 57 improves glycemic 57 FOLPI 57 Topiramate 57 synthetic peptide containing 57 LOVENOX R 57 DLTs 57 transdermal estrogen 57 budesonide inhalation suspension 57 ug kg 57 Tolerability 57 factor TNF receptor 57 histone deacetylase inhibitor 56 immunomodulating 56 Helicobacter pylori eradication 56 carcinoid syndrome 56 carbidopa levodopa 56 DP VPA 56 ziprasidone 56 PEG INTRON 56 maximal tolerated 56 statin monotherapy 56 SCIg 56 myelofibrosis polycythemia vera 56 Asentar 56 EndoTAGTM 1 56 Veramyst 56 doxorubicin cyclophosphamide 56 Valproic acid 56 hematological toxicity 56 clopidogrel Plavix 56 mGluR2 NAM 56 Submits Response 56 placebo controlled trials 56 limiting toxicity DLT 56 R bisoprolol Euthyrox 56 anticoagulant warfarin 56 mcg doses 56 EXJADE 56 pralatrexate injection folate analogue 56 + PH# 56 plus medroxyprogesterone acetate 56 LTRA 56 dose cohort 56 Aquavan Injection 56 partial opioid agonist 56 oxybutynin 56 BENICAR HCT 56 Cetrorelix pamoate 56 alkylating agent 56 biphasic insulin aspart 56 oxycodone CR 56 Fluticasone Propionate 56 HP Acthar Gel repository 56 EGFR tyrosine kinase inhibitor 56 Platinol ® cisplatin 56 APRISO 56 idiopathic thrombocytopenic purpura 56 Onco TCS 56 tolterodine ER 56 neurologic progression 56 paliperidone ER 56 QUADRAMET R 56 GRN# 56 treatment naive genotype 56 SomatoKine 56 AMMONUL R 56 continuous intravenous infusion 56 candidates Azedra TM 56 oral anti arrhythmic 56 PORxin TM 56 treat chronic sinusitis 56 symptomatic hypotension 56 ZOMIG 56 synthetic retinoid 56 antiplatelet agent 56 MAb therapy 56 Arno Therapeutics 56 oral proteasome inhibitor 56 Panzem ® 56 ABILIFY Injection 56 receiving prophylactic anticoagulation 56 TNF alpha antagonist 56 APEX AMI 56 pegylated interferon alfa 56 Lithobid 56 Vectical TM Ointment 56 nasal antihistamine 56 treprostinil 56 prospectively stratified 56 Orphan Drug designations 56 Serious adverse reactions 56 alpha 2A adrenoceptor 56 EDARBI 56 nanopharmaceutical 56 MCSP respectively 56 Raptiva r 56 MenACWY CRM 56 neuroleptic 56 DURECT proprietary 56 colesevelam 56 PegIFN 56 Apidra ® 56 Phase IIb clinical trials 56 CINQUIL 56 plus OBT 56 severe exacerbations 56 Migranal 56 L PPDS 56 PRECISE trial 56 Lupuzor ™ 56 angiotensin II receptor blocker 56 muscarinic receptor agonist 56 oral olanzapine 56 paliperidone 56 paclitaxel eluting stents 56 #.#g/day 56 IFN Beta CTP 56 enteric coated aspirin 56 AQ4N 56 volociximab 56 Medidur ™ FA 56 everolimus eluting stents 56 renal toxicity 56 constipation predominant irritable bowel 56 GERD migraine headaches 56 TheraCIM 56 Lofexidine 56 Solzira ™ 56 busulfan 56 oral salmon calcitonin 56 lopinavir r arm 56 morphine fentanyl 56 Lantus ® 56 DURIN TM 56 cetirizine 56 pulmonary exacerbations 56 Desvenlafaxine Succinate 56 postoperative ileus POI 56 oral ghrelin agonist 56 oral analgesics 56 LAF# 56 Novolimus 56 angiotensin converting enzyme inhibitor 56 HGS# 56 atazanavir ritonavir 56 morphometric vertebral fractures 56 R abatacept 56 Pyridorin TM 56 inhalations twice 56 alpha 2A 56 solifenacin 56 Soliris TM eculizumab 56 dosing frequency 56 metformin XR 56 anti emetic 56 Protexia ® 56 intermittent dosing 56 immuno modulatory 56 mcg QD 56 plus GP IIb 55 Aviptadil 55 nasal calcitonin product 55 ketorolac 55 Adefovir 55 AERx ® 55 evaluable subjects 55 GATTEX ™ 55 macular edema secondary 55 naltrexone SR 55 mg hydrochlorothiazide 55 Paliperidone palmitate 55 CYP#A# inhibitors 55 irbesartan 55 serotonin reuptake inhibitor 55 mg RDEA# 55 insulin secretagogue 55 O PPDS 55 DuraSite 55 Hematologic toxicity 55 eszopiclone 55 chills fever headache 55 INEGY 55 BioSante Pharmaceuticals Announces 55 H2 blocker 55 Friedreich Ataxia FRDA 55 indiplon capsules 55 dexanabinol 55 inhibit platelet function 55 events SAEs 55 sulfonylurea glimepiride 55 Gralise 55 orally disintegrating formulation 55 Adlea TM 55 Lamictal XR 55 immune modulating 55 mesalamine granules 55 events TEAEs 55 Nascobal Nasal Spray 55 coxib 55 gastrointestinal toxicity 55 adecatumumab 55 basal insulin 55 oral chemotherapeutic agent 55 potent topoisomerase II 55 Excellarate TM 55 mg simvastatin 55 mg clopidogrel 55 timolol 55 buspirone 55 severe renal impairment 55 GATTEX TM 55 limiting toxicity 55 mcg BID 55 tamoxifen Nolvadex ® 55 kidney urologic 55 Muscle relaxants 55 mg/m2 dose 55 pharmacokinetic PK profile 55 opioid receptor antagonist 55 Active Ulcerative Colitis 55 steroid dexamethasone 55 injectable atypical antipsychotic 55 mcg dose 55 mg metformin 55 subcutaneous infusion 55 quetiapine XR 55 conjugated equine estrogen 55 androgen suppression 55 prostanoid 55 Sinemet 55 pramipexole Mirapex 55 PEG Intron 55 Celecoxib 55 NR2B selective 55 aspirin heparin 55 CR nPR 55 Peg riba 55 PORxin TM platforms 55 tolerability profile 55 including eniluracil ADH 55 gemcitabine Gemzar 55 Methotrexate MTX 55 serum phosphate 55 pharmacodynamic effects 55 candidate XP# 55 beta blocker atenolol 55 dose proportionality 55 PEG Intron ® 55 Factor Xa inhibitor 55 Apidra R 55 IV bolus 55 ZOMIG Nasal Spray 55 dose corticosteroids 55 related hematological toxicity 55 Zyban bupropion 55 Lixivaptan 55 Viread tenofovir disoproxil fumarate 55 EVIZON TM squalamine lactate 55 Sanofi Pasteur Fluzone 55 sodium thiosulfate STS 55 intravenous AAT 55 Adenoscan 55 drug zotarolimus 55 CINTREDEKIN BESUDOTOX 55 polidocanol 55 Trofex TM 55 investigational therapies 55 conventional antipsychotics 55 long acting beta2 55 Atrigel 55 Trofex 55 Reports Preclinical Data 55 5 HT2A inverse 55 Sumatriptan 55 pouchitis 55 antiplatelets 55 Aerosurf 55 leading oral taxane 55 multi kinase inhibitor 55 CORLUX CORT # 55 postoperative chemotherapy 55 darifenacin 55 pill containing benazepril 55 neuropathy sparing 55 urate lowering therapy 55 angiotensin II receptor blockers 55 PDE# inhibitors 55 Zemiva TM 55 DASISION 55 investigational oral 55 FFNS 55 NOXAFIL Oral Suspension 55 selective estrogen receptor modulators 55 achieved ACR# 55 lopinavir r 55 Pharmos pipeline 55 muscarinic antagonist 55 EndoTAG TM 55 Phase IIb III 55 ENTOCORT EC 55 trial evaluating PRX# 55 calcium antagonist 55 Myocet 55 mg tid 55 tiotropium bromide 55 Fibrostat R 55 iroxanadine 55 QTc prolongation 55 ORADUR TM 55 #mg/m# [002] 55 mg QD 55 neuroprotective agent 55 TRISENOX 55 virologic breakthrough 55 KL4 Surfactant 55 mcg kg 55 budesonide formoterol 55 TEAEs 54 Tß4 54 tiapamil 54 oral FTY# 54 QAB# indacaterol 54 oral dihydropyrimidine dehydrogenase DPD 54 Ellence 54 topical hemostat 54 diarrhea nausea vomiting 54 R palivizumab 54 JANUVIA 54 tramadol HCl 54 OAB overactive bladder 54 Zomig 54 serum phosphorous 54 thorough QT 54 glucokinase activator 54 CYPHER ® 54 HRIG 54 COPEGUS 54 Interferon beta 54 platform HDL Mimetic 54 venous thromboembolic events 54 pioglitazone Actos 54 dirucotide MBP# 54 subcutaneous PRO 54 Atypical antipsychotics 54 Lamictal lamotrigine 54 glycoprotein GP IIb IIIa 54 lamotrigine 54 ramelteon 54 linaclotide treated 54 NNT = 54 histamine dihydrochloride 54 opioid narcotic 54 vasodilators 54 symptomatic VTE 54 serum urate 54 cutaneous T 54 efavirenz Sustiva 54 #.#/#.# mmHg [001] 54 INxin TM 54 anti secretory 54 NASDAQ AVNR 54 Oncaspar 54 PULMICORT RESPULES 54 serum calcium levels 54 sulphonylurea 54 atorvastatin Lipitor 54 myeloproliferative disorders 54 IV APAP 54 antifibrotic 54 #μg [001] 54 Viread Emtriva 54 LHRH agonists 54 gastrointestinal disorders ATI 54 oncologic outcomes 54 anti emetics 54 genotypic resistance 54 Cethrin 54 dizziness nausea diarrhea 54 moderately emetogenic 54 intravenous IV infusion 54 Surfaxin LS 54 risperidone olanzapine 54 angiographic restenosis 54 HuCAL antibodies 54 INVEGA ™ 54 EnteroMedics proprietary neuroblocking technology 54 Peginterferon alfa 2a 54 Uricase PEG 54 evaluating MGCD# [002] 54 PF # [002] 54 rhMBL 54 urethral bulking agent 54 ospemifene 54 Protexia R 54 GnRH antagonist 54 dosing cohort 54 non selective NSAIDs 54 aldosterone antagonist 54 SINGULAIR 54 antiresorptive drugs 54 Cellegesic 54 noninferior 54 rimonabant #mg/day 54 dose dose escalation 54 orally administered synthetic retinoid 54 AZILECT 54 sulphonylureas 54 recurrent VTE 54 PASI scores 54 cognitive impairment associated 54 Pilocarpine 54 Ostabolin C TM 54 subcutaneous methylnaltrexone 54 ALN HTT 54 alpha#beta# integrin 54 montelukast 54 GnRH agonist 54 inecalcitol 54 esomeprazole 54 personalized cellular immunotherapy 54 Cmax 54 statistically significant superiority 54 tamsulosin 54 atomoxetine 54 Dose escalation 54 RSV hospitalizations 54 aerosolized AAT 54 Nektar pulmonary 54 mg administered orally 54 TRADJENTA 54 subcutaneous injections 54 Free Survival PFS 54 NovoTTF #A 54 Homspera TM 54 Cutanea 54 β blocker 54 chemosensitizer 54 overlapping toxicities 54 adenoma recurrence 54 fluticasone propionate 54 molecular imaging radiopharmaceutical 54 MediGene focuses 54 Selective Electrochemical Tumor Ablation 54 JZP 54 Somatuline R Autogel R 54 rosuvastatin #mg 54 known sulfonamide allergy 54 dose atorvastatin 54 nasal aerosol 54 DITPA 54 mg dosed twice 54 rxRNA 54 acting inhaled anticholinergic 54 DAS# remission 54 gastrointestinal motility disorders 54 mg kg dose 54 platforms GVAX 54 INFERGEN 54 Keppra ® injection 54 HSP# inhibitors 54 DPX Survivac 54 XIFAXAN rifaximin 54 Lantus R 54 BXT # 54 EVIZON TM 54 antiplatelet 54 inhaled bronchodilator 54 unfractionated heparin 54 injectable investigational 54 interferon alfa 2a 54 Lopid 54 chronic thromboembolic pulmonary 53 transdermal estradiol 53 acromegalic patients 53 inhaled tobramycin 53 dyslipidemia hypertension diabetes 53 CIP TRAMADOL ER 53 factor G CSF 53 tiotropium 53 Brinavess 53 preventing restenosis 53 fluvastatin Lescol 53 PrevOnco 53 AFREZZA ® 53 Solazed 53 RHUCIN 53 Calixa 53 subcutaneous dosing 53 Pexeva 53 mg Pycnogenol 53 Pacira 53 sumatriptan naproxen sodium 53 cyclophosphamide doxorubicin vincristine 53 citalopram hydrobromide 53 vomiting CINV 53 didanosine associated 53 racemic albuterol 53 mg/m2/day 53 randomized #:#:# 53 LANTUS R 53 ropinirole 53 ddI 53 Zevalin R Ibritumomab 53 glyburide 53 intravenous methylnaltrexone 53 glipizide plus 53 echinacea tablets 53 Parathyroid hormone 53 epoetin beta 53 1mg dose 53 RenaZorb TM 53 ELADUR ™ 53 DepoBupivacaine TM 53 Hypersensitivity reactions 53 GI motility 53 NAGS deficiency 53 FOLFOX4 alone 53 investigational antiplatelet 53 product platforms AZX# 53 nevirapine Viramune 53 triglyceride TG 53 zidovudine lamivudine 53 Neuradiab 53 Lisofylline LSF 53 tramiprosate ALZHEMED TM 53 mTOR inhibitor 53 oral antidiabetes drugs 53 Pain Bust RII 53 secondary efficacy endpoint 53 adjunctively 53 Prestara 53 IXEMPRA 53 CONCERTA ® 53 serotonin norepinephrine reuptake inhibitors